Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.20
-1.30 (-2.52%)
May 14, 2025, 1:30 PM CST
-9.22%
Market Cap 3.67B
Revenue (ttm) n/a
Net Income (ttm) -150.37M
Shares Out 71.31M
EPS (ttm) -2.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 64,549
Average Volume 43,385
Open 50.40
Previous Close 51.50
Day's Range 49.10 - 52.00
52-Week Range 35.15 - 80.90
Beta 0.67
RSI 61.99
Earnings Date Aug 11, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630 drug, for which is in Phase II clinical trial. It is also developing SNP-810 is in phase II clinical trial for use in Pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for acetamino... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.